“Machine Learning and Animal Experiments Identify ID3 and SLC22A4 as Potential Targets for Stroke Recovery and Immunotherapy”

https://pubmed.ncbi.nlm.nih.gov/38112574

This study used machine learning and animal experiments to identify ID3 and SLC22A4 as potential immune-related signatures with altered expression in ischemic stroke, suggesting they may be new targets for promoting functional recovery and immunotherapy after stroke.